Tufton Capital Management Cuts Holdings in Colgate-Palmolive (NYSE:CL)

Tufton Capital Management cut its position in shares of Colgate-Palmolive (NYSE:CL) by 3.1% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 26,150 shares of the company’s stock after selling 825 shares during the quarter. Tufton Capital Management’s holdings in Colgate-Palmolive were worth $2,377,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Centricity Wealth Management LLC purchased a new position in Colgate-Palmolive in the fourth quarter valued at about $27,000. Union Bancaire Privee UBP SA purchased a new position in Colgate-Palmolive in the fourth quarter valued at about $32,000. Bernard Wealth Management Corp. purchased a new position in Colgate-Palmolive in the fourth quarter valued at about $36,000. Reston Wealth Management LLC purchased a new position in Colgate-Palmolive in the third quarter valued at about $42,000. Finally, Roxbury Financial LLC bought a new stake in shares of Colgate-Palmolive in the fourth quarter valued at approximately $43,000. 80.41% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several analysts have recently issued reports on the stock. Piper Sandler lowered their price target on shares of Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating on the stock in a research report on Monday, January 6th. Stifel Nicolaus lowered their price target on shares of Colgate-Palmolive from $95.00 to $93.00 and set a “hold” rating on the stock in a research report on Monday, February 3rd. JPMorgan Chase & Co. lowered their price target on shares of Colgate-Palmolive from $103.00 to $97.00 and set an “overweight” rating on the stock in a research report on Monday, February 3rd. TD Cowen lowered their price target on shares of Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating on the stock in a research report on Wednesday, January 8th. Finally, Barclays lowered their price target on shares of Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating on the stock in a research report on Friday, January 17th. One research analyst has rated the stock with a sell rating, ten have given a hold rating and twelve have issued a buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $101.16.

Colgate-Palmolive Price Performance

CL stock opened at $90.23 on Friday. Colgate-Palmolive has a one year low of $85.32 and a one year high of $109.30. The stock has a market cap of $73.22 billion, a PE ratio of 25.63, a P/E/G ratio of 4.20 and a beta of 0.44. The firm has a 50 day simple moving average of $88.75 and a two-hundred day simple moving average of $95.58. The company has a debt-to-equity ratio of 13.40, a current ratio of 0.92 and a quick ratio of 0.58.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings data on Friday, January 31st. The company reported $0.91 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same period in the previous year, the business posted $0.87 earnings per share. On average, analysts predict that Colgate-Palmolive will post 3.75 EPS for the current fiscal year.

Colgate-Palmolive Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, February 14th. Stockholders of record on Tuesday, January 21st were paid a $0.50 dividend. The ex-dividend date of this dividend was Tuesday, January 21st. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.22%. Colgate-Palmolive’s dividend payout ratio (DPR) is 56.82%.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.